The dose-dependent effect of Tołpa Peat Preparation on the humoral response of mice immunized with sheep erythrocytes. 1993

B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
Department of Pharmacology and Toxicology, Agriculture University, Wrocław, Poland.

The Balb/c strain mice were immunized by single intraperitoneal administration of 0.2 cm3 of 10% sheep erythrocyte suspension (SRBC). Tołpa Peat Preparation (TPP) used in the study was a peat-derived substance obtained in prof. St. Tołpa's laboratory. It was given to mice intraperitoneally, 4 times at 24-hour intervals. The first dose was administered 2 hours before immunization. Testing was performed with the following doses: 0.5, 2.5, 5, 10, 25, 50, 100 and 250 mg/kg. The determinations comprised the number of spleen cells producing anti-SRBC haemolysins, the level of serum haemagglutinins to SRBC (19S+7S and 7S types) and the percentage of splenocytes forming spontaneous E-rosettes. It was found that the effect of TPP on these immunologic parameters of the mice immunized with SRBC was dose-dependent. The effect potentiating the humoral response occurred for the doses of 0.5-10 mg/kg. The doses of 25 and 50 mg/kg did not affect the immunologic response to SRBC, while the doses of 100 and 250 mg/kg had a suppressive effect. The impact of TPP on the percentage of splenocytes forming E-rosettes was also dose-dependent, but in this case stimulating activity was observed for the doses of 2.5-25 mg/kg.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005260 Female Females
D006388 Hemagglutinins Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc. Isohemagglutinins,Exohemagglutinins,Hemagglutinin
D006812 Humic Substances Organic matter in a state of advanced decay, after passing through the stages of COMPOST and PEAT and before becoming lignite (COAL). It is composed of a heterogenous mixture of compounds including phenolic radicals and acids that polymerize and are not easily separated nor analyzed. (E.A. Ghabbour & G. Davies, eds. Humic Substances, 2001). Humic Acid,Humic Acids,Humic Substance,Sodium Huminate,Acid, Humic,Acids, Humic,Huminate, Sodium,Substance, Humic,Substances, Humic
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
April 1984, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1987, Archivum immunologiae et therapiae experimentalis,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
B Obmińska-Domoradzka, and M Switała, and J Debowy, and T Garbulński
January 1993, Acta poloniae pharmaceutica,
Copied contents to your clipboard!